eFotoXpress, Inc. (EFOT) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswereFotoXpress, Inc. (EFOT) trades at $0.00002. eFotoXpress, Inc. specializes in developing and selling software for image compression. Their products cater to retail, enterprise, medical, and radiology sectors, offering solutions for efficient image handling. Sector: Technology.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for EFOT: EFOT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
eFotoXpress, Inc. (EFOT) Technology Profile & Competitive Position
eFotoXpress, Inc., established in 1996, develops and sells image compression software solutions for diverse sectors, including retail, enterprise, and medical imaging. The company's product suite addresses the need for efficient image handling and transfer, particularly in bandwidth-constrained environments, operating within the application software segment of the technology sector.
What Is the Investment Thesis for EFOT?
eFotoXpress, Inc. operates in the niche market of image compression software. With a market capitalization of $0.00B and negative ROE of -86.4%, the company faces significant profitability challenges. The debt-to-equity ratio stands at 59.71, indicating a moderate level of leverage. A negative Beta of -5.02 suggests an inverse correlation with the market. Future growth hinges on expanding its market reach in the medical sector with eFotoXpress-Medical and PASS. Key risks include intense competition and the need for continuous innovation to maintain a competitive edge. Investors should closely monitor the company's ability to improve profitability and generate positive free cash flow, which currently stands at $-0.00B.
Based on FMP financials and quantitative analysis
EFOT Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited market presence.
- Negative ROE of -86.4% reflects poor profitability and inefficient use of equity.
- Debt/Equity Ratio of 59.71 suggests moderate leverage; debt is more than half of equity.
- Negative Free Cash Flow of $-0.00B indicates the company is not generating enough cash from operations to cover investments.
- Beta of -5.02 suggests the stock moves inversely to the market, but also indicates high volatility and potential risk.
Who Are EFOT's Competitors?
EFOT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MNDO MIND C.T.I. Ltd. | $0.98 | -2.97% | $20.0M | 78 5-pillar |
| IDN Intellicheck, Inc. | $2.26 | -0.44% | $46.1M | 75 5-pillar |
| NTWK NetSol Technologies, Inc. | $6.17 | +3.70% | $74.4M | 84 5-pillar |
| TRAK ReposiTrak, Inc. | $8.08 | -0.12% | $147M | 75 5-pillar |
| PERF Perfect Corp. | $1.92 | +0.52% | $197M | 85 5-pillar |
| IMMR Immersion Corporation | $7.27 | -1.62% | $245M | 82 5-pillar |
| RMNI Rimini Street, Inc. | $4.18 | -1.42% | $399M | 73 5-pillar |
| MTLS Materialise NV | $8.55 | +0.59% | $502M | 73 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EFOT's Key Strengths?
Specialized image compression software for niche markets.
- Solutions tailored for medical imaging with eFotoXpress-Medical and PASS.
- Long-standing presence in the industry since 1996.
- Proprietary technology and algorithms.
What Are EFOT's Weaknesses?
Limited market share and brand recognition.
- Negative ROE and free cash flow indicate financial instability.
- Dependence on a narrow range of products and services.
- Small number of employees (37) limits scalability.
What Are the Key Risks for EFOT?
Negative return on equity (-86.4%) — the business is not currently generating profit on shareholder capital.
- Intense competition from larger software companies with greater resources.
- Rapid technological advancements rendering existing products obsolete.
- Limited financial resources and negative free cash flow.
- Dependence on a small number of key customers and markets.
- Regulatory changes in the healthcare industry affecting the use of image compression software.
What Are EFOT's Competitive Advantages?
- Specialized solutions for the medical imaging market.
- Proprietary image compression algorithms.
- Established presence in the niche market of image compression software.
- Long-standing relationships with customers in the healthcare industry.
What Does EFOT Do?
eFotoXpress, Inc., originally incorporated as American Multiplexer Corporation in 1996, rebranded in 2005 to reflect its focus on image compression technology. The company develops and markets a suite of software utilities designed to compress large images, addressing the challenges of storage and transmission. Its flagship product, eFotoXpress-Standard Version, targets the retail market, enabling users to compress images for email. The eFotoXpress-Premium Version offers lossless compression for enterprise applications, ensuring image quality is maintained. Recognizing the specific needs of the healthcare industry, eFotoXpress-Medical provides tailored solutions for medical imaging. PASS (Picture Archiving and Sharing System) caters to the medical radiology field, streamlining image management and distribution. Headquartered in Fremont, California, eFotoXpress serves a global customer base across various industries.
What Products and Services Does EFOT Offer?
- Develops eFotoXpress-Standard Version for compressing images for email in the retail market.
- Offers eFotoXpress-Premium Version, a lossless compression software for the enterprise market.
- Provides eFotoXpress-Medical for specialized medical applications.
- Markets PASS, a solution tailored for the medical radiology field.
- Creates software utilities designed to compress large images for efficient storage and transfer.
- Offers solutions for various sectors, including retail, enterprise, and medical.
How Does EFOT Make Money?
- Direct sales of software licenses to end-users.
- Subscription-based model for cloud-based services.
- Partnerships with medical device manufacturers and healthcare providers.
- Customized software development for specific client needs.
What Industry Does EFOT Operate In?
eFotoXpress, Inc. operates within the application software industry, a segment characterized by rapid technological advancements and intense competition. The market for image compression software is driven by the increasing volume of digital images and the need for efficient storage and transmission solutions. Companies like COUV, CYPJ, HOILF, MVLA, and MZPS represent the competitive landscape. eFotoXpress focuses on niche markets like medical imaging, which could provide a degree of differentiation. The overall software industry is experiencing growth, but eFotoXpress's ability to capitalize on this trend depends on its innovation and marketing strategies.
Who Are EFOT's Key Customers?
- Retail consumers needing image compression for email.
- Enterprises requiring lossless compression for archiving.
- Medical professionals and healthcare providers.
- Radiology departments in hospitals and clinics.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
eFotoXpress, Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Fremont, US. The company is led by CEO Edward S. C. Tan. EFOT has traded publicly since 2009.
Key Financial Metrics
Return on equity for eFotoXpress, Inc. stands at -86.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -48.7%, showing how much profit it generates from its asset base. A current ratio of 1.02 indicates the company holds enough short-term assets to cover its near-term obligations.
EFOT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
EFOT Latest News
No recent news available for EFOT.
EFOT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EFOT.
Price Targets
Wall Street price target analysis for EFOT.
EFOT MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EFOT; grades run from A+ (80-100) to F (below 30).
Leadership: Edward S. C. Tan
CEO
Edward S. C. Tan serves as the CEO of eFotoXpress, Inc. His background includes extensive experience in managing technology companies. He has been instrumental in guiding eFotoXpress through various stages of its development, including its rebranding in 2005. His leadership focuses on driving innovation and expanding the company's market reach. He oversees a team of 37 employees, focusing on software development and sales.
Track Record: Under Edward S. C. Tan's leadership, eFotoXpress has focused on developing specialized image compression solutions for the medical sector. Key milestones include the launch of eFotoXpress-Medical and PASS, tailored for medical imaging and radiology. His strategic decisions have aimed to position the company as a niche player in the competitive software market. However, the company still faces challenges in achieving profitability.
EFOT OTC Market Information
The OTC Other tier, where eFotoXpress trades, represents the lowest tier of the OTC market. Unlike stocks listed on major exchanges like NYSE or NASDAQ, companies on OTC Other often have limited financial disclosure requirements and may not meet minimum listing standards. This tier typically includes companies with higher risk profiles due to factors such as financial distress, regulatory issues, or limited operating history. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks compared to exchange-listed securities.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in EFOT.
- Low trading volume and liquidity can lead to price volatility.
- The OTC Other tier designation indicates a higher risk profile compared to exchange-listed stocks.
- Potential for limited regulatory oversight and investor protection.
- The company's financial performance and ability to continue as a going concern are uncertain.
- Verify the availability and accuracy of financial statements.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Understand the regulatory environment in which the company operates.
- Determine the liquidity of the stock and potential trading costs.
- Research any legal or regulatory issues involving the company.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1996.
- eFotoXpress has developed specialized software solutions for the medical imaging market.
- The company has a dedicated management team led by CEO Edward S. C. Tan.
EFOT Technology Stock FAQ
What do analysts say about EFOT stock?
As of March 16, 2026, there is no available analyst coverage or consensus on EFOT stock due to its OTC listing and micro-cap status.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on available company data and may be limited due to the company's OTC listing.
- Financial metrics are based on the most recent available data and may not reflect current performance.
- The analysis is for informational purposes only and does not constitute investment advice.